vs
Lantheus Holdings, Inc.（LNTH）与RANGE RESOURCES CORP（RRC）财务数据对比。点击上方公司名可切换其他公司
RANGE RESOURCES CORP的季度营收约是Lantheus Holdings, Inc.的1.9倍（$786.9M vs $406.8M），RANGE RESOURCES CORP净利率更高（22.8% vs 13.3%，领先9.5%），RANGE RESOURCES CORP同比增速更快（18.0% vs 4.0%），过去两年RANGE RESOURCES CORP的营收复合增速更高（14.6% vs 4.9%）
Lantheus Holdings是一家全球性医疗保健企业，专注于研发、生产及商业化创新诊断显像剂与相关解决方案，产品覆盖肿瘤学、心脏病学、泌尿学等核心医疗领域，主要市场遍及北美及全球其他重点地区。
Range Resources Corporation是一家总部位于美国得克萨斯州沃斯堡的天然气勘探开采企业，核心运营区域为马塞勒斯页岩地层，是该地区拥有土地面积最大的运营商，专注于天然气资源的勘探、开发与生产业务，在北美油气开发领域具备深厚的行业积累。
LNTH vs RRC — 直观对比
营收规模更大
RRC
是对方的1.9倍
$406.8M
营收增速更快
RRC
高出14.0%
4.0%
净利率更高
RRC
高出9.5%
13.3%
两年增速更快
RRC
近两年复合增速
4.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $406.8M | $786.9M |
| 净利润 | $54.1M | $179.1M |
| 毛利率 | 59.2% | 94.5% |
| 营业利润率 | 19.0% | — |
| 净利率 | 13.3% | 22.8% |
| 营收同比 | 4.0% | 18.0% |
| 净利润同比 | 558.8% | 88.8% |
| 每股收益（稀释后） | $0.86 | $0.75 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LNTHRRC
| Q4 25 | $406.8M | $786.9M | ||
| Q3 25 | $384.0M | $655.3M | ||
| Q2 25 | $378.0M | $699.6M | ||
| Q1 25 | $372.8M | $846.3M | ||
| Q4 24 | $391.1M | $667.0M | ||
| Q3 24 | $378.7M | $567.9M | ||
| Q2 24 | $394.1M | $513.2M | ||
| Q1 24 | $370.0M | $598.8M |
净利润LNTHRRC
| Q4 25 | $54.1M | $179.1M | ||
| Q3 25 | $27.8M | $144.3M | ||
| Q2 25 | $78.8M | $237.6M | ||
| Q1 25 | $72.9M | $97.1M | ||
| Q4 24 | $-11.8M | $94.8M | ||
| Q3 24 | $131.1M | $50.7M | ||
| Q2 24 | $62.1M | $28.7M | ||
| Q1 24 | $131.1M | $92.1M |
毛利率LNTHRRC
| Q4 25 | 59.2% | 94.5% | ||
| Q3 25 | 57.9% | 92.5% | ||
| Q2 25 | 63.8% | 95.0% | ||
| Q1 25 | 63.8% | 93.1% | ||
| Q4 24 | 63.5% | 93.7% | ||
| Q3 24 | 63.9% | 94.3% | ||
| Q2 24 | 64.9% | 93.4% | ||
| Q1 24 | 65.4% | 94.7% |
营业利润率LNTHRRC
| Q4 25 | 19.0% | — | ||
| Q3 25 | 11.4% | — | ||
| Q2 25 | 23.3% | — | ||
| Q1 25 | 27.4% | — | ||
| Q4 24 | 29.1% | — | ||
| Q3 24 | 35.3% | — | ||
| Q2 24 | 26.1% | — | ||
| Q1 24 | 28.8% | — |
净利率LNTHRRC
| Q4 25 | 13.3% | 22.8% | ||
| Q3 25 | 7.2% | 22.0% | ||
| Q2 25 | 20.8% | 34.0% | ||
| Q1 25 | 19.6% | 11.5% | ||
| Q4 24 | -3.0% | 14.2% | ||
| Q3 24 | 34.6% | 8.9% | ||
| Q2 24 | 15.8% | 5.6% | ||
| Q1 24 | 35.4% | 15.4% |
每股收益（稀释后）LNTHRRC
| Q4 25 | $0.86 | $0.75 | ||
| Q3 25 | $0.41 | $0.60 | ||
| Q2 25 | $1.12 | $0.99 | ||
| Q1 25 | $1.02 | $0.40 | ||
| Q4 24 | $-0.18 | $0.38 | ||
| Q3 24 | $1.79 | $0.21 | ||
| Q2 24 | $0.88 | $0.12 | ||
| Q1 24 | $1.87 | $0.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $359.1M | $204.0K |
| 总债务越低越好 | $568.7M | $1.2B |
| 股东权益账面价值 | $1.1B | $4.3B |
| 总资产 | $2.2B | $7.4B |
| 负债/权益比越低杠杆越低 | 0.52× | 0.28× |
8季度趋势，按日历期对齐
现金及短期投资LNTHRRC
| Q4 25 | $359.1M | $204.0K | ||
| Q3 25 | $382.0M | $175.0K | ||
| Q2 25 | $695.6M | $134.0K | ||
| Q1 25 | $938.5M | $344.6M | ||
| Q4 24 | $912.8M | $304.5M | ||
| Q3 24 | $866.4M | $277.4M | ||
| Q2 24 | $757.0M | $251.1M | ||
| Q1 24 | $718.3M | $343.1M |
总债务LNTHRRC
| Q4 25 | $568.7M | $1.2B | ||
| Q3 25 | $567.9M | $1.2B | ||
| Q2 25 | $566.8M | $1.2B | ||
| Q1 25 | $566.1M | $1.7B | ||
| Q4 24 | $565.3M | $1.7B | ||
| Q3 24 | $613.0K | $1.7B | ||
| Q2 24 | $563.2M | $1.7B | ||
| Q1 24 | $562.5M | $1.8B |
股东权益LNTHRRC
| Q4 25 | $1.1B | $4.3B | ||
| Q3 25 | $1.1B | $4.2B | ||
| Q2 25 | $1.2B | $4.1B | ||
| Q1 25 | $1.2B | $3.9B | ||
| Q4 24 | $1.1B | $3.9B | ||
| Q3 24 | $1.2B | $3.9B | ||
| Q2 24 | $1.0B | $3.9B | ||
| Q1 24 | $945.5M | $3.8B |
总资产LNTHRRC
| Q4 25 | $2.2B | $7.4B | ||
| Q3 25 | $2.3B | $7.2B | ||
| Q2 25 | $2.1B | $7.1B | ||
| Q1 25 | $2.1B | $7.4B | ||
| Q4 24 | $2.0B | $7.3B | ||
| Q3 24 | $2.0B | $7.2B | ||
| Q2 24 | $1.9B | $7.3B | ||
| Q1 24 | $1.8B | $7.4B |
负债/权益比LNTHRRC
| Q4 25 | 0.52× | 0.28× | ||
| Q3 25 | 0.51× | 0.29× | ||
| Q2 25 | 0.49× | 0.29× | ||
| Q1 25 | 0.49× | 0.43× | ||
| Q4 24 | 0.52× | 0.43× | ||
| Q3 24 | 0.00× | 0.44× | ||
| Q2 24 | 0.55× | 0.44× | ||
| Q1 24 | 0.59× | 0.46× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $90.2M | $257.5M |
| 自由现金流经营现金流 - 资本支出 | $81.4M | — |
| 自由现金流率自由现金流/营收 | 20.0% | — |
| 资本支出强度资本支出/营收 | 2.2% | — |
| 现金转化率经营现金流/净利润 | 1.67× | 1.44× |
| 过去12个月自由现金流最近4个季度 | $354.1M | — |
8季度趋势，按日历期对齐
经营现金流LNTHRRC
| Q4 25 | $90.2M | $257.5M | ||
| Q3 25 | $105.3M | $247.5M | ||
| Q2 25 | $87.1M | $336.2M | ||
| Q1 25 | $107.6M | $330.1M | ||
| Q4 24 | $157.7M | $217.9M | ||
| Q3 24 | $175.1M | $245.9M | ||
| Q2 24 | $84.7M | $148.8M | ||
| Q1 24 | $127.2M | $331.9M |
自由现金流LNTHRRC
| Q4 25 | $81.4M | — | ||
| Q3 25 | $94.7M | — | ||
| Q2 25 | $79.1M | — | ||
| Q1 25 | $98.8M | — | ||
| Q4 24 | $141.4M | — | ||
| Q3 24 | $159.3M | — | ||
| Q2 24 | $73.5M | — | ||
| Q1 24 | $119.0M | — |
自由现金流率LNTHRRC
| Q4 25 | 20.0% | — | ||
| Q3 25 | 24.7% | — | ||
| Q2 25 | 20.9% | — | ||
| Q1 25 | 26.5% | — | ||
| Q4 24 | 36.1% | — | ||
| Q3 24 | 42.0% | — | ||
| Q2 24 | 18.7% | — | ||
| Q1 24 | 32.2% | — |
资本支出强度LNTHRRC
| Q4 25 | 2.2% | — | ||
| Q3 25 | 2.8% | — | ||
| Q2 25 | 2.1% | — | ||
| Q1 25 | 2.3% | — | ||
| Q4 24 | 4.2% | — | ||
| Q3 24 | 4.2% | — | ||
| Q2 24 | 2.8% | — | ||
| Q1 24 | 2.2% | — |
现金转化率LNTHRRC
| Q4 25 | 1.67× | 1.44× | ||
| Q3 25 | 3.79× | 1.72× | ||
| Q2 25 | 1.11× | 1.42× | ||
| Q1 25 | 1.47× | 3.40× | ||
| Q4 24 | — | 2.30× | ||
| Q3 24 | 1.34× | 4.85× | ||
| Q2 24 | 1.36× | 5.18× | ||
| Q1 24 | 0.97× | 3.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LNTH
| Radiopharmaceutical Oncology | $240.2M | 59% |
| Definity | $85.3M | 21% |
| Strategic Partnerships And Other | $23.3M | 6% |
| Techne Lite | $21.0M | 5% |
| Licenseand Royalty Revenues | $17.4M | 4% |
| Other | $13.6M | 3% |
| Other Precision Diagnostics | $5.9M | 1% |
RRC
| Natural Gas Natural Gas Liquids And Oil Sales | $745.5M | 95% |
| Brokered Natural Gas And Marketing | $41.3M | 5% |
